CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension

Journal of Hypertension

Volumn 27, Issue 8, 2009, Pages 1594-1601

  Palatini, Paolo ^a   Ceolotto, Giulio ^a   Ragazzo, Fabio ^a   Dorigatti, Francesca ^a   Saladini, Francesca ^a   Papparella, Italia ^a   Mos, Lucio ^b   Zanata, Giuseppe ^c   Santonastaso, Massimo ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Town Hospital   (Italy)

^c Town Hospital   (Italy)

Author keywords

Caffeine; Coffee; CYP1A2; Hypertension; Polymorphism

Indexed keywords

ADRENALIN; CAFFEINE; CYTOCHROME P450 1A2;

ADRENALIN URINE LEVEL; ADULT; ALLELE; ANALYSIS OF COVARIANCE; ANTIHYPERTENSIVE THERAPY; ARTICLE; COFFEE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HAZARD RATIO; HETEROZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

EID: 68449093192     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832ba850     Document Type: Article

References (36)

1. Stensvold I, Tverdal A, Foss OP. The effect of coffee on blood lipids and blood pressure: results from the Norwegian cross-sectional study, men and women, 40-42 years. J Clin Epidemiol 1989; 42:877-884.
2. Salvaggio A, Periti M, Miano L, Zambelli C. Association between habitual coffee consumption and blood pressure levels. J Hypertens 1990; 8:585-590.
3. Kirchhoff M, Torp-Pedersen C, Kougaard K, Jacobsen TJ, Sjol A, Munch M, et al. Casual blood pressure in a general Danish population: relation to age, sex, weight, height, diabetes, serum lipids and consumption of coffee, tobacco and alcohol. J Clin Epidemiol 1994; 47:469-474.
4. Narkiewicz K, Maraglino G, Biasion T, Rossi G, Sanzuol F, Palatini P. Interactive effect of cigarettes and coffee on daytime systolic blood pressure in patients with mild essential hypertension. J Hypertens 1995; 13:965-970.
5. Jee SH, He J, Whelton PK, Suh I, Klag MJ. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 1999; 33:647-652.
6. Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a metaanalysis of randomized controlled trials. J Hypertens 2005; 23:921-928.
7. Klag MJ, Wang NY, Meoni LA, Brancati FL, Cooper LA, Liang KY, et al. Coffee intake and risk of hypertension: the Johns Hopkins precursors study. Arch Intern Med 2002; 162:657-662.
8. Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC. Habitual caffeine intake and the risk of hypertension in women. JAMA 2005; 294:2330-2335.
9. Uiterwaal CS, Verschuren MW, Bueno-de-Mesquita HB, Ocké M, Geleijnse JM, Boshuizen HC. Coffee intake and incidence of hypertension. Am J Clin Nutr 2007; 85:718-723.
10. Gu L, Gonzalez FJ, Kalow W, Tang BK. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 1992; 2:73-77.
11. Sachse C, Brockmoller J, Bauer S, Roots I. Functional significance of a C to A polymorphism in intron 1 of the cytochrome P450 1A2 (CYP1A2) gene tested with caffeine. Br J Clin Pharmacol 1999; 47:445-449.
12. Han XM, Ou-Yang DS, Lu PX, Jiang CH, Shu Y, Chen XP, et al. Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734 polymorphisms of human CYP1A2. Pharmacogenetics 2001; 11:429-435.
13. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 2006; 295:1135-1141.
14. Palatini P, Graniero G, Mormino P, Nicolosi L, Mos L, Visentin P, et al. Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST trial. Circulation 1994; 90:2870-2876.
15. Sartori M, Semplicini A, Siffert W, Mormino P, Mazzer A, Pegoraro F, et al. G-protein beta3-subunit gene 825T allele and hypertension: a longitudinal study in young grade I hypertensives. Hypertension 2003; 42:909-914.
16. Palatini P, Mormino P, Mos L, Mazzer A, Dorigatti F, Zanata G, et al. Microalbuminuria, renal function and development of sustained hypertension: a longitudinal study in the early stage of hypertension. J Hypertens 2005; 23:175-182.
17. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 2004; 164:2126- 2134.
18. Casiglia E, Paleari CD, Petucco S, Bongiovì S, Colangeli G, Baccilieri MS, et al. Haemodynamic effects of coffee and purified caffeine in normal volunteers: a placebo-controlled clinical study. J Hum Hypertens 1992; 6:95-99.
19. Bloomgarden ZT. American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC. Diab Care 2003; 26:933-939.
20. National Center for Biotechnology Information. dbSNP Home Page. http://www.ncbi.nlm.nih.gov/SNP/index.html. [Accessed 10 May 2006]
21. Treating mild hypertension. Report of the British Hypertension Society working party. BMJ 1989;98:694-698.
22. Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993; 306:983-987.
23. -1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Sub-Committee. Blood Press 1999; 1:9-43.
24. -2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
25. Palatini P, Dorigatti F, Santonastaso M, Cozzio S, Biasion T, Garavelli G, et al. Association between coffee consumption and risk of hypertension. Ann Med 2007; 39:545-553.
26. Funatsu K, Yamashita T, Nakamura H. Effect of coffee intake on blood pressure in male habitual alcohol drinkers. Hypertens Res 2005; 28:521-527.
27. Rasmussen BB, Brix TH, Kyvik KO, Brosen K. The interindividual differences in the 3-demethylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 2002; 12:473-478.
28. Bonita JS, Mandarano M, Shuta D, Vinson J. Coffee and cardiovascular disease: In vitro, cellular, animal, and human studies. Pharmacol Res 2007; 55:187-198.
29. Huang J, de Paulis T, May J. Antioxidant effects of dihydrocaffeic acid in human EA.hy926 endothelial cells. J Nutr Biochem 2004; 15:722-729.
30. Suzuki A, Yamamoto N, Jokura H, Yamamoto M, Fujii A, Tokimitsu I, et al. Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats. J Hypertens 2006; 24:1065-1073.
31. Watanabe T, Arai Y, Mitsui Y, Kusaura T, Okawa W, Kajihara Y, et al. The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clin Exp Hypertens 2006; 28:439-449.
32. Bellet S, Roman L, Decastro O, Kim KE, Kershbaum A. Effect of caffeine ingestion on catecholamine release. Metabolism 1969; 18:288-291.
33. Levi L. The effect of coffee on the function of the sympatho- adrenalmedullary system in men. Acta Medica Scand 1967; 181:431-438.
34. Tiwari AK, Deshpande SN, Rao AR, Bhatia T, Mukit SR, Shriharsh V, et al. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects. I: association of CYP1A2 gene polymorphism. Pharmacogenomics J 2005; 5:60-69.
35. Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, et al. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 2007; 16:912-916.
36. Schreiber GB, Robins M, Maffeo CE, Masters MN, Bond AP, Morganstein D. Confounders contributing to the reported associations of coffee or caffeine with disease. Prev Med 1988; 17:295-309.